Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study

PURPOSE: As a novel small-molecule vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor (VEGFR2-TKI), Methylsulfonic apatinib (apatinib) exhibits a specific antitumor effect in various solid tumors via inhibition of angiogenesis. The present study was performed to evaluate the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ge, Gong, Shuai, Pang, Lina, Hou, Lixia, He, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126718/
https://www.ncbi.nlm.nih.gov/pubmed/34012920
http://dx.doi.org/10.3389/fonc.2021.659217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126718/
https://www.ncbi.nlm.nih.gov/pubmed/34012920
http://dx.doi.org/10.3389/fonc.2021.659217

Ejemplares similares